As of 2025-07-16, the Relative Valuation of Jiangsu Hengrui Medicine Co Ltd (600276.SS) is 23.65 CNY. This relative valuation is based on P/E multiples. With the latest stock price at 57.22 CNY, the upside of Jiangsu Hengrui Medicine Co Ltd based on Relative Valuation is -58.7%.
The range of the Relative Valuation is 19.69 - 31.34 CNY.
| Range | Selected | |
| Trailing P/E multiples | 22.5x - 29.2x | 24.1x |
| Forward P/E multiples | 17.1x - 22.6x | 18.6x |
| Fair Price | 19.69 - 31.34 | 23.65 |
| Upside | -65.6% - -45.2% | -58.7% |
| Date | P/E |
| 2025-07-15 | 53.35 |
| 2025-07-14 | 53.34 |
| 2025-07-11 | 53.05 |
| 2025-07-10 | 53.70 |
| 2025-07-09 | 53.32 |
| 2025-07-08 | 49.79 |
| 2025-07-07 | 49.09 |
| 2025-07-04 | 49.66 |
| 2025-07-03 | 48.92 |
| 2025-07-02 | 48.72 |
| 2025-07-01 | 48.91 |
| 2025-06-30 | 48.39 |
| 2025-06-27 | 48.44 |
| 2025-06-26 | 48.56 |
| 2025-06-25 | 49.37 |
| 2025-06-24 | 48.62 |
| 2025-06-23 | 48.45 |
| 2025-06-20 | 48.26 |
| 2025-06-19 | 48.09 |
| 2025-06-18 | 48.31 |
| 2025-06-17 | 48.33 |
| 2025-06-16 | 50.12 |
| 2025-06-13 | 50.25 |
| 2025-06-12 | 52.05 |
| 2025-06-11 | 51.01 |
| 2025-06-10 | 51.40 |
| 2025-06-09 | 50.68 |
| 2025-06-06 | 50.16 |
| 2025-06-05 | 50.24 |
| 2025-06-04 | 51.55 |
| 2025-06-03 | 51.17 |
| 2025-05-30 | 51.04 |
| 2025-05-29 | 50.44 |
| 2025-05-28 | 50.58 |
| 2025-05-27 | 49.81 |
| 2025-05-26 | 49.74 |
| 2025-05-23 | 50.81 |
| 2025-05-22 | 51.84 |
| 2025-05-21 | 52.16 |
| 2025-05-20 | 50.77 |
| 2025-05-19 | 49.84 |
| 2025-05-16 | 50.21 |
| 2025-05-15 | 50.06 |
| 2025-05-14 | 49.32 |
| 2025-05-13 | 47.77 |
| 2025-05-12 | 47.26 |
| 2025-05-09 | 49.24 |
| 2025-05-08 | 48.07 |
| 2025-05-07 | 48.03 |
| 2025-05-06 | 47.55 |